San Francisco health officials over the years have turned to cartoon characters in order to relay important health messages to men who have sex with men in attention grabbing ways.
Only 4 percent of sexually active gay and bisexual men in the United States are using PrEP, according to a recently published study, showing that more must be done to reach everyone who could benefit from it.
The most common attributes people want to see in the next San Francisco health director are prioritizing collaboration, support for nonprofits, and mitigating health disparities among minority communities.
The U.S. Food and Drug Administration has approved two new HIV treatment medications containing doravirine, a next-generation non-nucleoside reverse transcriptase inhibitor.
The latest San Francisco HIV epidemiology report shows that while the number of new infections continues to decline, African-Americans and homeless people have persistently higher infection rates and poorer outcomes.
The proportion of people with HIV who achieve viral suppression has risen dramatically across the United States over the past two decades, but young black men are not seeing the same gains, according to a new study.
Government policies can work against achieving an end to HIV by limiting access to prevention and treatment for the most heavily affected groups, according to research presented at the 22nd International AIDS Conference last week in Amsterdam.
A gay Union City Kaiser Permanente physician has been awarded the LGBTQ Leadership Award by the California chapter of the National Diversity Council for his longtime advocacy work.
Show us your pride and advertise in our annual San Francisco Pride edition. Space reservations will be due at 12noon on Friday, June 15 with ad materials due June 18, Monday, at 5pm.
But as I prepare to attend what is the biggest men's leather and kink event of its kind in the world, I'm reflecting on some of the events I've been attending this past week here locally in San Francisco.
The U.S. Food and Drug Administration this week approved Truvada PrEP for adolescents, making the once-daily HIV prevention pill more widely available to a group with a disproportionately high risk of infection.
